Financings in Brief: Medical Device Technologies Inc.
This article was originally published in The Gray Sheet
Medical Device Technologies Inc.: Raises $1.7 mil. in a private placement bridge financing. The company says proceeds will support development of its Cell Recovery System (CRS) and Intercranial Pressure Management Device (ICP), and will allow it "to go forward with marketing" of its Personal Alarm System for monitoring infection barriers around patients. The funds will be repaid upon completion of the company's pending $5.3 mil. preferred stock offering, announced during the summer ("The Gray Sheet" Aug. 7, 1995, p. 20)...
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.